75 related articles for article (PubMed ID: 25554638)
1. Anti-metastatic effect and mechanisms of Wenshen Zhuanggu Formula in human breast cancer cells.
Han XH; Wang CL; Xie Y; Ma J; Zhang XH; Hu QW; Lin G; Liu S; Lu JG
J Ethnopharmacol; 2015 Mar; 162():39-46. PubMed ID: 25554638
[TBL] [Abstract][Full Text] [Related]
2. Wenshen Zhuanggu formula effectively suppresses breast cancer bone metastases in a mouse Xenograft model.
Li JJ; Chen WL; Wang JY; Hu QW; Sun ZP; Zhang S; Liu S; Han XH
Acta Pharmacol Sin; 2017 Oct; 38(10):1369-1380. PubMed ID: 28414206
[TBL] [Abstract][Full Text] [Related]
3. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of six coumarins in normal and breast cancer bone-metastatic mice after oral administration of Wenshen Zhuanggu Formula.
Chen W; Li J; Sun Z; Wu C; Ma J; Wang J; Liu S; Han X
J Ethnopharmacol; 2018 Oct; 224():36-44. PubMed ID: 29803570
[TBL] [Abstract][Full Text] [Related]
5. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
[TBL] [Abstract][Full Text] [Related]
6. [Effects of serum containing Fructus Cnidii and Psoralea corylifolia on highly metastatic human breast cancer cell line MDA-MB-231BO and bone marrow stromal cell line ST-2].
Liu S; Song XY; Wu CY; Han XH; Liu LL; Liu JW; Xu YC
Zhong Xi Yi Jie He Xue Bao; 2010 Sep; 8(9):877-82. PubMed ID: 20836979
[TBL] [Abstract][Full Text] [Related]
7. Osthole inhibits the migration and invasion of highly metastatic breast cancer cells by suppressing ITGα3/ITGβ5 signaling.
Chen YQ; Song HY; Zhou ZY; Ma J; Luo ZY; Zhou Y; Wang JY; Liu S; Han XH
Acta Pharmacol Sin; 2022 Jun; 43(6):1544-1555. PubMed ID: 34426644
[TBL] [Abstract][Full Text] [Related]
8. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effects of osthole, psoralen and aconitine on invasive activities of breast cancer MDA-MB-231BO cell line and the mechanisms].
Guo BF; Liu S; Ye YY; Han XH
Zhong Xi Yi Jie He Xue Bao; 2011 Oct; 9(10):1110-7. PubMed ID: 22015193
[TBL] [Abstract][Full Text] [Related]
10. The β-catenin signaling pathway induces aggressive potential in breast cancer by up-regulating the chemokine CCL5.
Yasuhara R; Irié T; Suzuki K; Sawada T; Miwa N; Sasaki A; Tsunoda Y; Nakamura S; Mishima K
Exp Cell Res; 2015 Oct; 338(1):22-31. PubMed ID: 26363360
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
Sun Y; Wang X; Zhou Q; Lu Y; Zhang H; Chen Q; Zhao M; Su S
Oncol Rep; 2015 Jan; 33(1):338-46. PubMed ID: 25370743
[TBL] [Abstract][Full Text] [Related]
12. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
13. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
[TBL] [Abstract][Full Text] [Related]
14. Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro.
Zhong Z; Tan W; Chen X; Wang Y
Eur J Pharmacol; 2014 Aug; 737():1-10. PubMed ID: 24824922
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase-1 and -2.
Clarke MR; Imhoff FM; Baird SK
Mol Carcinog; 2015 Oct; 54(10):1214-9. PubMed ID: 24819588
[TBL] [Abstract][Full Text] [Related]
16. Effect of truncated neurokinin-1 receptor expression changes on the interaction between human breast cancer and bone marrow-derived mesenchymal stem cells.
Zhou Y; Zuo D; Wang M; Zhang Y; Yu M; Yang J; Yao Z
Genes Cells; 2014 Sep; 19(9):676-91. PubMed ID: 25130457
[TBL] [Abstract][Full Text] [Related]
17. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
18. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
19. The potential to target CCL5/CCR5 in breast cancer.
Velasco-Velázquez M; Xolalpa W; Pestell RG
Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of bone metastasis from breast carcinoma by rosmarinic acid.
Xu Y; Jiang Z; Ji G; Liu J
Planta Med; 2010 Jul; 76(10):956-62. PubMed ID: 20157877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
